Osimertinib
Back to searchMolecule Structure
Scientific Name
Osimertinib
Description of the Drug
Osimertinib is a tyrosine kinase inhibitor used in the treatment of certain types of non-small cell lung carcinoma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09330
http://www.drugbank.ca/drugs/DB09330
Brand Name(s)
Tagrisso
Company Owner(s)
Astrazeneca Pharmaceuticals Lp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Epidermal growth factor receptor erbB1 | SINGLE PROTEIN | INHIBITOR | CHEMBL203 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL14660911 | ||
| PharmGKB | PA166131626 | ||
| Human Metabolome Database | HMDB0248778 | ||
| DrugBank | DB09330 | ||
| PubChem: Thomson Pharma | 163477648 | ||
| PubChem | 71496458 | ||
| LINCS | LSM-6344 | ||
| Nikkaji | J3.291.102A | ||
| PDBe | YY3 | ||
| BindingDB | 50029668 | ||
| DrugCentral | 5062 | ||
| ChemicalBook | CB02677059 | ||
| Guide to Pharmacology | 7719 | ||
| rxnorm | OSIMERTINIB | OSIMERTINIB MESYLATE | TAGRISSO |
| ChEBI | 90943 | ||
| ZINC | ZINC000098023177 |
